Trial Profile
Randomised, Double-blind, Placebo-controlled, Phase I/II Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 01 Feb 2014
Price :
$35
*
At a glance
- Drugs Influenza virus delta-NS1 vaccine (Primary)
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Adverse reactions; First in man
- Sponsors AVIR Green Hills Biotechnology
- 09 Jan 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record
- 07 Nov 2011 Status changed from recruiting to active, no longer recruiting, according to an AVIR Green Hills Biotechnology media release.
- 11 Aug 2011 Planned end date changed from 1 Jul 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.